Macerich CO

The Macerich Company has successfully closed an offering of 14,000,000 shares of common stock and subsequently exercised its option to purchase an additional 2,100,000 shares, with proceeds intended for acquisitions and general corporate purposes.

The Macerich Company has entered into an underwriting agreement for the offer and sale of 14,000,000 shares of common stock.

The Macerich Company's annual meeting saw the election of eight directors, approval of executive compensation, and ratification of KPMG LLP as its auditor for fiscal year 2026.

The Macerich Company presented an investor presentation on June 1, 2026, detailing its 'Path Forward Plan v 3.0,' emphasizing a strategic shift towards high-quality Class A malls and significant progress in operational improvements and leverage reduction.

The Macerich Company announced the completion of a stock offering, raising capital to repay debt and fund strategic investments.

The Macerich Company announced its first quarter 2026 financial results, reporting a reduced net loss and a slight increase in adjusted Funds from Operations (FFO) compared to the prior year.

The Macerich Company's Q1 2026 Form 10-Q filing details a net loss of $36.35 million, a decrease from the prior year, alongside strategic portfolio adjustments and a strengthened credit facility.

Macerich reports improved Q3 2025 net loss and increased FFO, driven by active portfolio management and leasing gains, despite higher interest expenses and ongoing debt challenges.

Macerich reports a net loss in Q2 2025 despite strong leasing spreads and revenue growth, driven by strategic portfolio adjustments and increased interest expenses.

Macerich's Q1 2025 shows increased leasing revenue and a reduced net loss, driven by strategic acquisitions and dispositions, as the company progresses with its 'Path Forward Plan'.

Macerich's Q3 2024 results show a net loss, impacted by asset write-downs and joint venture losses, but also include gains from strategic dispositions and increased leasing revenue.

Macerich's Q2 2024 results show a net income of $252 million, driven by strategic asset sales and re-evaluations, alongside the unveiling of a new 'Path Forward' plan.

Macerich reports a net loss in 2025 but shows FFO growth and positive leasing trends amid strategic portfolio adjustments and ongoing debt management efforts.

Macerich's 2024 10-K filing highlights strategic acquisitions, dispositions, and financing activities aimed at deleveraging and strengthening its core retail assets.

Macerich's 10-K filing describes the terms and provisions of its common stock registered under the Securities Exchange Act of 1934, including voting, dividend, and liquidation rights, as well as restrictions on transfer and ownership to maintain REIT status.

Macerich Co. Director Andrea M. Stephen reported a transaction involving phantom stock units, convertible on a 1-for-1 basis to common stock.

Enrique Hernandez Jr., a Director at Macerich Co., reported the acquisition of phantom stock units and an increase in beneficial ownership of common stock.

Enrique Hernandez Jr., a Director at The Macerich Company, received an award of 6,720 restricted stock units under the company's equity incentive plan.

Macerich Director Andrea M. Stephen was granted restricted stock units under the company's equity incentive plan.

Macerich Co. director Diana Laing was awarded restricted stock units under the company's equity incentive plan.

Director Marianne Lowenthal was awarded 6,720 restricted stock units by The Macerich Company as non-cash compensation.

The Macerich Company announces its 2026 Annual Meeting of Stockholders, to be held virtually on June 1, 2026, with key proposals including director elections and executive compensation.

Macerich Company announces its 2025 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and auditor ratification.

Macerich Company announces its 2025 Annual Meeting of Stockholders to be held virtually on June 2, 2025, featuring proposals for director elections, executive compensation approval, and auditor ratification.

Macerich Company has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.

Macerich is asking stockholders to approve an amendment to its Employee Stock Purchase Plan to increase the share reserve by 500,000 shares.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 10.2% of Macerich Co.'s common stock as of April 30, 2026.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 9.3% of Macerich Co.'s common stock as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 13,593,968 shares, representing 5.29% of Macerich Co.'s common stock, as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 9.99% in Macerich Co. (MAC) as of March 31, 2026, holding over 25.6 million shares.

Smead Capital Management, Inc., along with William W. Smead and Cole W. Smead, has filed a Schedule 13G, reporting beneficial ownership of 12,155,332.57 shares of Macerich Co. common stock, representing 4.74% of the class.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 4.1% beneficial ownership stake in The Macerich Company's common stock.